Stimalia

TLDR

Stimalia develops TraumaTone, a percutaneous bioelectronic implant targeting the stellate ganglion for treatment-resistant PTSD.

Overview

Stimalia is a bioelectronic medicine company offering TraumaTone, described as the world's first percutaneous bioelectronic implant for PTSD. The device is designed to address treatment-resistant cases by modulating the body's alarm system through stellate ganglion targeting.